EISSN 2148-5607

TJG IS INDEXED IN SCI-EXPANDED AND PUBMED IMPACT FACTOR: 1.4

Turkish Journal of Gastroenterology

35 414 2024

Submission to First Decision = 31 Days

HIGHLY CITED ARTICLES

HBV and HCV are the risk factors in CCA

Tan et al.

Serum resolvin levels in irritable bowel syndrome

Karatay and Gül Utku

Microbial improvement after intervention

Qian et al.

18F-FDGPET/CT in gallbladder carcinoma

Arslan et al.

Bezoar in endoscopy

Gökbulut et al.

Effect of vitamin D on CD40L gene expression in UC

Sharifi et al.

ERCP for acute cholangitis

Khamaysi and Taha

Inborn metabolic causes of fatty liver disease

Yıldız and Sivri

Gastric and small intestinal TSA

Kiremitci et al.

COVID-19 in Hepatology and Liver transplantation

Kabaçam et al.

Editorial

A case of terbinafine associated hepatic injury

Kadir DEMİR ¹ , Atilla ÖKTEN ¹ , Oktay YEĞİNSU ¹ , Zeynel MUNGAN ¹ , Sabahattin KAYMAKOĞLU ² , M. Derya ONUK ³ , Selim GÜREL ⁴ , Nedim İNCE ⁵ , Osman ESERLER ⁵

Author Affiliation(s)

1.

İstanbul Üniversitesi, İstanbul Tıp Fakültesi Gastroenteropatoloji Bilim Dalı ve Patoloji anabilim Dalı, İstanbul

2.

Department of Gastroenterology, İstanbul University, İstanbul School of Medicine, İstanbul

3.

Atatürk Üniversitesi Tıp Fakültesi İç Hastalıkları Kliniği, Erzurum

4.

Department of Gastroenterology, Uludağ University, School of Medicine, Bursa

5.

İstanbul Tıp Fakültesi, Gastroenterohepatoloji, İç Hastalıkları Anabilim Dalı, İstanbul

Turk J Gastroenterol 1996; 7: 90-92

Keywords : terbinafine, drug-induced hepatitis, hepatotoxicity.

Read: 1468 Downloads: 1316 Published: 25 July 2019

Volume 7, Issue 1, March 1996

Previous Article

Files